Navigation Links
Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
Date:10/22/2008

MINNEAPOLIS, Oct. 22 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH) consolidated net earnings for the quarter ended September 30, 2008 increased 23.9% to $28.6 million or $.74 per diluted share compared with $23.1 million or $.58 per diluted share for the quarter ended September 30, 2007. Net earnings as a percentage of net sales improved from 39.8% in the first quarter of last year to 41.2% for the quarter ended September 30, 2008. The improvement in net earnings was mainly due to increased consolidated net sales. The unfavorable impact on consolidated net earnings of the change in exchange rates used to convert foreign currencies (primarily British pound sterling and Euros) to U.S. dollars was $310,000 ($.01 per diluted share) for the quarter ended September 30, 2008.

Consolidated net sales for the quarter ended September 30, 2008 were $69.3 million, an increase of 19.6% from the same prior-year quarter. Consolidated net sales were favorably affected by the strength of foreign currencies as compared to the U.S. dollar. Excluding the effect of changes in foreign currency exchange rates, consolidated net sales increased 18.4% for the quarter ended September 30, 2008 from the quarter ended September 30, 2007. The quarter ended September 30, 2008 included one more selling day than the comparable prior-year quarter.

Biotechnology net sales, which include sales by R&D Systems' Biotechnology Division, R&D Systems China and BiosPacific, for the quarter ended September 30, 2008, were $46.1 million, an increase of 18.7% from the same prior-year quarter. R&D Europe's net sales for the quarter were $18.9 million, an increase of 22.6% from the same prior-year quarter. R&D Europe's net sales increased 18.4% for the quarte
'/>"/>

SOURCE Techne Corporation
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Techne Corporation Announces Share Repurchase Authorization
2. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
3. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
4. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
7. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
8. BioElectronics Corporation Announces Singapore and Malaysia Sales
9. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
10. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
11. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... The Houston Technology Center ... its 9th annual gala, "A Celebration of ... that have made a significant impact on the ... The Houston Technology Center named Beth ... year,s honoree. As the Founder and CEO of TechTrans ...
(Date:5/21/2012)... -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Richard ... World Stem Cells & Regenerative Medicine Congress in ... at 12:30 PM. Mr. Garr,s presentation, "Stem Cell ... therapy trial in ALS, its neurogenic small molecule ... an overview on plans to expand the cellular ...
(Date:5/18/2012)...  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that ... CEO, will be presenting at the Seventh Annual ... (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The title ... Offer Attractive Targets for Active and Passive Immunotherapy." ... at the Intercontinental Hotel in Boston from 10:15-11:30 ...
(Date:5/17/2012)... -- The " Anesthesia Drugs Market ... analyzes and studies the U.S. market for intravenous anesthesia drugs ... U.S., potential buyers, export & import system for controlled substances in ... market data tables and in-depth TOC of   " ...   U.S. Market Entry Study ...
Breaking Biology Technology:Leading Technology Incubator Honors Extraordinary Entrepreneurs 2Leading Technology Incubator Honors Extraordinary Entrepreneurs 3Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 2Anesthesia Drugs Market in U.S. worth $7 Billion by 2015: MarketsandMarkets 3
... SAN DIEGO, May 28 Gen-Probe Incorporated,(Nasdaq: GPRO ... Europe its,APTIMA(R) HPV Assay, a highly specific molecular diagnostic ... which causes cervical,cancer. The APTIMA HPV Assay has been ... European Union countries., "The CE marking and launch ...
... AMT), a leader in the field of human gene ... Annual Meeting of,the American Society of Gene Therapy in ... its lead product AMT-011 on May 29., About ... therapy platform that to date appears to,circumvent many if ...
... Mass., May 28 Abt Associates announced that,it ... Financial Officer.,Small most recently served as Senior Vice ... Automation Inc., a $700 million,provider of factory and ... industry. Prior to joining Brooks Automation he held ...
Other Biology Technology:Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 3Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 4Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 5AMT Announces Presentations During the 11th Annual Meeting of the ASGT 2Abt Associates Names Richard Small Vice President and Chief Financial Officer 2
(Date:5/21/2012)... A tool commonly used by financial strategists to determine ... portfolio was used to develop a diversified portfolio of ... conservation purposes given the uncertainty about climate change. , ... the history of a stock, University of Illinois environmental ... the historical climate data of the Prairie Pothole Region ...
(Date:5/21/2012)... SEATTLE, May 21, 2012 Researchers from Seattle Biomedical ... the University of Edinburgh have uncovered new knowledge related ... parasites are able to bind to cells in the ... form of the disease. Three related papers will be ... ( Proceedings of the National Academy of Sciences ), ...
(Date:5/21/2012)...  Chiltern International Limited (Chiltern), a global contract ... recognized with a CRO Leadership Award in all ... The awards are given by Life Science Leader ... Insight. Glenn Kerkhof , ... recognized as a CRO leader in the Quality, ...
Breaking Biology News(10 mins):Financial tool considered climate change uncertainty to select land for conservation 2Financial tool considered climate change uncertainty to select land for conservation 3New discoveries about severe malaria 2Chiltern Wins CRO Leadership Award From Life Science Leader 2Medication Telemonitoring Improves Compliance and Behavior in NIH Study 14209 1Medication Telemonitoring Improves Compliance and Behavior in NIH Study 14209 2Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 1Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 2Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 3Payless and Shoppers Take Steps In the Fight Against Breast Cancer This October 57984 4Osseon Signs International Distribution Agreement With MBA Incorporado 57980 1Osseon Signs International Distribution Agreement With MBA Incorporado 57980 2Osseon Signs International Distribution Agreement With MBA Incorporado 57980 3
... filamentous viruses make up a large fraction of known ... the viral damage to crop plants throughout the world. ... have been revealed by scientists using a variety of ... Brookhaven National Laboratory and collaborating institutions. , These findings, ...
... In pre-clinical studies, vitamin C appears to substantially reduce ... Sloan-Kettering Cancer Center. , These new findings, published in ... a publication of the American Association of Cancer Research ... but the study,s authors say the same mechanism may ...
... Women who have a history of dieting or ... an inappropriate amount of weight during pregnancy. In a ... Journal of the American Dietetic Association, researchers ... report that restrained eating behaviors prior to pregnancy were ...
Other Biology News:Structures of important plant viruses determined 2Structures of important plant viruses determined 3Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs 2Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs 3New study indicates link between weight gains during pregnancy and dieting history 2
Anti-DAP-1, Rabbit Monoclonal Immunogen: KLH-conjugated synthetic peptide corresponding to the C-terminal region of human DAP-1. Molecular Weight: 11 kDa Quality Assurance: Routinely eval...
Wnt-1 (G-19)...
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein....
Myt 1 (N-17)...
Biology Products: